Florida Auditor General Report Criticizes DBPR
A report by the Florida Auditor General has criticized the Department of Business and Professional Regulation (DBPR) for its lack of oversight over prescription drug entities.
Matthew Tracy, Deputy Auditor General, presented the report to the House Administration Budget Subcommittee, slamming DBPR for "a wholesale dropping of the ball" in monitoring controlled substances.
- The audit covered the period from July 2022 to December 2023.
- The analysis focused on wholesaler and manufacturer prescription drug purchasing activity.
Matthew Tracy's presentation slammed regulators for 'a wholesale dropping of the ball.'
The report criticized DBPR's performance in checking whether purchasing levels follow state law and regulations.
Author's summary: Florida DBPR criticized for lack of oversight.
More News
- Prop 50 co-author Assemblymember Gregg Hart urges people to vote | News Channel 3-12
- A roadmap for change: Building the health workforce Canadians deserve - Healthy Debate
- Sanaenomics Ignores Voter Needs | Economy | The ORIENTAL ECONOMIST
- There’s math behind this maddening golf mishap
- Rich Rodriguez provides thoughts on proposed sports gambling for college athletes - Dominion Post
- SEMA 2025: Holley Offers A Complete Fox Mustang Fuel System
- Prop 50 Could Affect California and Future Elections – What Do You Think? | News Channel 3-12
- Editorial: Federal food stamp funding and Nassau County